Drug news
LumiHeal receives CE mark approval for Wound Healing-KLOX Tech
KLOX Technologies has received CE mark approval in Europe for its topical photo-converter gel, LumiHeal, as a Class IIb Medical Device for the treatment of acute and chronic Wounds. This gel is part of KLOX's non-invasive, and patented BioPhotonic platform which is designed to promote healing of wounds while addressing bacterial contamination. KLOX plans to independently commercialize LumiHeal in Europe in 2015.